# A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

> **NCT05215418** · PHASE4 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 565 (actual)

## Conditions studied

- Blood Pressure

## Interventions

- **DRUG:** VI-0521
- **DRUG:** Phentermine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05215418
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-25
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-04-17
- **Target enrollment:** 565 (ACTUAL)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05215418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05215418, "A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05215418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*